Stay updated on Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page shows a revision tag updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a platform update. This change does not modify the study details, eligibility criteria, outcomes, or other content presented on the page.
    Difference
    0.1%
    Check dated 2026-07-04T04:11:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.0 to v3.6.2, signaling a minor platform update to the Study page. This change does not modify study content or visible functionality.
    Difference
    0.1%
    Check dated 2026-06-27T02:03:40.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added recruitment status text No longer looking for participants and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) with a formatting update to the Intervention/Treatment label. Removed the old Intervention / Treatment heading and updated the revision to Revision: v3.6.0 replacing v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T16:07:17.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.5, replacing the previous v3.5.4. This reflects a minor maintenance update rather than a content change.
    Difference
    0.1%
    Check dated 2026-06-05T11:31:50.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new revision label, v3.5.4, was added to the study documents and the previous label v3.5.3 was removed, indicating an updated documentation version in the record. This reflects an update to the study's protocol/documentation in the ClinicalTrials.gov record.
    Difference
    0.1%
    Check dated 2026-05-15T05:36:56.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    This change updates the site/revision version shown in the page footer from v3.5.2 to v3.5.3, indicating a minor release of the ClinicalTrials.gov page display.
    Difference
    0.1%
    Check dated 2026-04-24T06:28:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.